Dummy Infusion: Clinical Trials

3 completed. 3 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	3	Completed 3

Follow Dummy Infusion: new trials by email Literature Review of Dummy Infusion trials Research Report on Dummy Infusion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) TBP-PI-HBr, Imipenem-cilastatin, Dummy Infusion - Urinary Tract Infection, Acute Pyelonephritis	Phase 3	Completed	Spero Therapeutics	1690	2023-12-21	2026-03-10
Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) TBPM-PI-HBr, Ertapenem, Dummy Infusion - Complicated Urinary Tract Infection, Acute Pyelonephritis	Phase 3	Completed	Spero Therapeutics	1372	2019-06-03	2022-07-25
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) ThermoDox, Dummy infusion - Hepatocellular Carcinoma	Phase 3	Completed	Imunon	554	2014-06-01	2024-08-20

Conditions studied

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Urinary Tract Infections (1)

Sponsors

Spero Therapeutics (2)  ·  Imunon (1)

Countries

United States (3)  ·  Bulgaria (2)  ·  Estonia (2)  ·  Georgia (2)  ·  Hungary (2)  ·  Latvia (2)  ·  Moldova (2)  ·  Poland (2)  ·  Romania (2)  ·  Serbia (2)  ·  Slovakia (2)  ·  South Africa (2)  ·  Argentina (1)  ·  Bosnia and Herzegovina (1)  ·  Brazil (1)

Top investigators

Chen Min Hua, MD (1)  ·  David Hong, MD (1)  ·  David Melnick, MD (1)  ·  Ricardo Lencioni, MD (1)  ·  Ronnie Tung Ping Poon, MD (1)

Results publications

PMID 35388666

NIH funding

2018 (1), 2023 (1)